(HGH) Return on Equity ROE from the second quarter 2026 to second quarter 2014 and annually, average high and low, overall ranking from Jun 30 2026 to Dec 31 2014 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
  (HGH)
    Sector •    Industry •
   Industry •
   Sector •

's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for in the second quarter 2026?
achieved a return on average equity (ROE) of 18.47 % in its second quarter 2026, this is above HGH's average return on equity of 4.42%.
s equity during the 12 months ending in the second quarter 2026 are valued at $15 billion

ROE has advanced compared to 13.64% in the fourth quarter 2022, due to net income growth.

Within the industry achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the fourth quarter 2022 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Dec 31 2014)
IV. Quarter
Y / Y Equity Change 38.01 % -10.81 % -10.86 % -28.47 % -
Y / Y Net Income Change 239.79 % 52.58 % - -24.85 % 30.38 %
Net Income (TTM) in Millions 2,797 1,881 1,677 675 798
Return On Equity (TTM) 18.47 % 13.64 % 11.79 % 4.61 % 5.01 %
HGH's Total Ranking # # # # #
Equity (TTM) in Millions 19,633 14,340 13,631 12,955 14,226
Seq. Equity Change 36.91 % 5.2 % 5.22 % -8.93 % -11.52 %
Seq. Net Income Change 119.26 % 10.65 % 43.82 % -2.62 % -1.55 %

Back to HGH Management Effectiveness >> HGH's 5 Years Annual ROE >> Compare HGH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
9.83 %
4.42 %
-2.17 %
  (Jun 30 2013)





HGH Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2011)
2011		 (Dec 31 2010)
2010		 (Dec 31 2007)
2009
Total Equity in Millions 13,631 22,910 18,700 9,360 0
Y / Y Equity Change -40.5 % 22.51 % 99.79 % - -
Net Income in Millions 1,819 662 1,636 2,949 0
Y / Y Net Income Change 174.77 % -59.54 % -44.52 % - -
Return On Equity 13.34 % 2.89 % 8.75 % 31.51 % -

Back to HGH Management Effectiveness >> HGH's 5 Years Annual ROE >> Compare HGH ROE to its Competitors




Annual Roe Comment
In 2022 ROE improved to 13.34 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Industry Roe Trends and Statistics
Sector Return On Equity Statistics
HGH's' Return on Equity at Yahoo Finance
HGH's Roe Ratio versus Industry, Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HGH's Competitors
Subscribers only: Roe for 's Suppliers
Subscribers only: Return On Equity for HGH's Customers




Companies with similar Return On Equity at Jun 30 2026, within Sector ROE
Gladstone Investment Corporationde  28.11 %
Hercules Capital Inc   17.16 %
Main Street Capital Corporation  14.81 %
Msc Income Fund Inc  13.47 %
Trinity Capital Inc   12.49 %
Triplepoint Venture Growth Bdc Corp   11.38 %
Capital Southwest Corporation  11.32 %
Fidus Investment Corporation  10.54 %
Chicago Atlantic Bdc Inc   10.45 %
Gladstone Capital Corp  10.25 %
Stellus Capital Investment Corp  8.05 %
Green Thumb Industries Inc.  7.24 %
Whitehorse Finance inc  6.83 %
Ares Capital Corporation  6.78 %
Bain Capital Specialty Finance Inc   5.79 %
Sixth Street Specialty Lending Inc   5.64 %
Nuveen Churchill Direct Lending Corp   5.40 %
Prospect Capital Corp  4.84 %
Blue Owl Technology Finance Corp   4.80 %
Pennantpark Floating Rate Capital Ltd   4.78 %
Blackstone Secured Lending Fund  4.78 %
Goldman Sachs Bdc Inc   4.17 %
Saratoga Investment Corp  4.00 %
Blue Owl Capital Corp  3.98 %

Date modified: 2026-10-07T18:09:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.